Identification of a Novel De Novo HECW2 Gene Pathogenic Variant in a Fetus With Cardiac Abnormalities Authors: Kristina Nimchenko, Bettina Bessieres, Gihad E Chalouhi, Antonia Pop, Vanina Castaigne, Bertrand Stos, Marie‐Paule Beaujard, Diane Roy, Daniela Laux, Tania Attie‐Bitach Published: 2026 ABSTRACT Summary What's already known about this topic?◦ HECW2 pathogenic variants have been primarily associated with neurodevelopmental disorders, with limited evidence linking the gene to cardiac abnormalities.What does this study add?◦This study reinforces and further delineates the rare prenatal cardiac phenotype of HECW2 related disorders by reporting a novel de novo missense variant associated with severe fetal hypertrophic cardiomyopathy and hydrops. Our findings add critical clinical weight to the emerging literature on HECW2 associated cardiac comorbidities, underscoring the necessity of fetal echocardiography, prenatal genetic screening, and precise multidisciplinary counseling in high‐risk pregnancies. Keywords: cardiac anomalies, fetal hydrops, HECW2, long QT syndrome, prenatal diagnosis Fetal Phenotype A non‐consanguineous healthy couple was referred during their sixth pregnancy (Table 1A). An ultrasound at 21 gestational weeks (WG) revealed right ventricular dilatation and pulmonary artery (PA) stenosis. Fetal echocardiography at 24 WG further indicated PA stenosis with retrograde ductal flow and a hypokinetic right ventricle with absent diastolic filling, suggesting potential progression toward right ventricular hypoplasia. At 33 weeks, the ultrasound revealed fetal hydrops (Figure 1A) and an irregular heartbeat of approximately 100 beats per minute. Fetal death occurred at 34 WG. TABLE 1AClinical data.Parental detailsPrenatal phenotype (HPO terms)Obstetrics historyFamily historyOutcome Maternal age 36 Paternal age 42 Right ventricular dilatation (HP:0005133) Pulmonary artery stenosis (HP:0004415) Lateral ventricular asymmetry (HP:0100960) Hydrops fetalis (HP:0001789) Arrhythmia (HP:0011675) Abnormal right ventricular function (HP:0033118) Combined first‐screen: 1/8562Non consanguineous couple Fetal death in utero at 34WG Fetopathological examination: Depressed nasal ridge (HP:0000457) Short philtrum (HP:0000322) Hypertrophic cardiomyopathy (HP:000163) Hypoplastic tricuspid valve (HP:0011573) Endocardial fibroelastosis (HP:0001706) Hydrops fetalis (HP:0001789) Pulmonary Hypoplasia (HP:0002089) Hypoxemia (HP:0012418) Abbreviation: WG, Weeks of gestation. Clinical data. Maternal age 36 Paternal age 42 Right ventricular dilatation (HP:0005133) Pulmonary artery stenosis (HP:0004415) Lateral ventricular asymmetry (HP:0100960) Hydrops fetalis (HP:0001789) Arrhythmia (HP:0011675) Abnormal right ventricular function (HP:0033118) Fetal death in utero at 34WG Fetopathological examination: Depressed nasal ridge (HP:0000457) Short philtrum (HP:0000322) Hypertrophic cardiomyopathy (HP:000163) Hypoplastic tricuspid valve (HP:0011573) Endocardial fibroelastosis (HP:0001706) Hydrops fetalis (HP:0001789) Pulmonary Hypoplasia (HP:0002089) Hypoxemia (HP:0012418) Abbreviation: WG, Weeks of gestation. Ultrasound and clinical data of the fetus. (A) Hypokinetic RV with hyperechoic wall and absent diastolic filling with pericardial effusion (thick arrow). Hydrops is confirmed with the association of skin edema (thin arrow) and ascites with pericardial effusion; (B) Histological analysis of the heart revealed endocardial fibroelastosis, characterized by the presence of sinuous bundles; (C) Discrete cerebral hypotrophy with vasodilatation (black arrow) and biometric measurements consistent with 31 weeks of gestation and neuronal apoptosis; (D) Histopathological analysis indicating ischemic lesions (black arrow) and loss of differentiation between white and gray matter. Diagnostic Method Written informed consent was obtained from the couple for fetal autopsy and genetic analysis. Chromosome microarray analysis showed no genomic imbalances. An autopsy was performed, including imaging, macroscopic, and histopathological examination of all organs. Genome sequencing (GS) was conducted at the national genomic laboratory SeqOIA using DNA extracted from fetal tissue and parental blood. Results and Interpretations GS analysis revealed a heterozygous de novo variant in HECW2 ENST00000644978.1 c.4511C > T, p.(Ser1504Phe) located in the HECT catalytic domain of the protein and classified as pathogenic (PM5, PP3, PM1, PM2, PS2) (Table 1B). TABLE 1BIndex case genetic findings.Procedure (gest age)Direct/culturePerformed testSecondary confirmatory testGene (name; REFSEQ)Known disease (OMIM)VariantACMG classificationCriteria appliedInheritance & zygosityInterpretationClinVar submissionFetal tissue 34 + 3 WG and parental blood samples—Trio‐based genome sequencingSanger HECW2 (NM_0644978.1) Neurodevelopmental disorder with hypotonia, seizures, and absent language (OMIM #617268)c.4511C > T, p.(Ser1504Phe)PathogenicACMG: PM1 moderate, PM5 moderate, PP3 moderate, PM2 supporting, PS2 strong De novo Heterozygous PathogenicSUB16255215Abbreviations: PM, moderate evidence of pathogenicity; PP, supporting evidence of pathogenicity. Index case genetic findings. Abbreviations: PM, moderate evidence of pathogenicity; PP, supporting evidence of pathogenicity. Pregnancy Outcomes and Neonatal Findings Fetal death occurred at 34 WG. The eutrophic female fetus presented with dysmorphological features, including a depressed nasal ridge and short philtrum, generalized edema (hydrops), and pulmonary hypoplasia. Signs of hypoxia were observed on histology (hematopoiesis and erythroblastosis in multiple organs). Cardiac anomalies included biventricular hypertrophic cardiomyopathy associated with hypoplasia of the tricuspid valve and pulmonary artery, bicuspid pulmonary valve, and fibroelastosis of the right ventricle (Figure 1B). Brain examination showed stasis accompanied by petechial hemorrhagic lesions (Figure 1C–D). Discussion HECW2 or NEDL2 (OMIM 617245) encodes an E3 ubiquitin ligase of the Nedd4 family with an N‐terminal C2 domain for membrane targeting, multiple WW domains for substrate recognition, and a C‐terminal HECT catalytic domain. While HECW2 pathogenic variants lead to neurodevelopmental disorders (NDD) [1, 2], recent studies have identified four patients with cardiac comorbidities associated with HECW2 mutations [2, 3, 4]. In a first study, HECW2 pathogenic variants were found in 5 trios with NDD [1]. Notably, no cardiac phenotypes were described in these patients. Then, in a large cohort of 3309 probands with NDD, six unique de novo missense variants in HECW2 were identified [2]. One patient showed cardiac arrhythmias, suggesting a potential link between HECW2 and a cardiac phenotype. Later on, 15 distinct heterozygous missense variants in HECW2 were reported in 22 NDD cases [3], including two novel patients with cardiac abnormalities, and one previously reported [2]. Interestingly, a de novo missense variant affected the same HECW2 Ser1504 codon involved in our presented fetus. Lastly, a heterozygous HECW2 de novo missense variant was identified in an infant with muscle hypotonia, seizures, developmental delays, and congenital long QT syndrome that was revealed prenatally [4]. Altogether, these data suggest a potential role for HEWC2 in cardiac ion channel regulation, supported by evidence of its involvement in ubiquitin‐mediated ion channel regulation and in cardiac arrhythmias. [5, 6]. Furthermore, recent functional data by He et al. (2023) demonstrated a molecular link between HECW2 dysregulation and cardiomyocyte hypertrophy, providing a mechanistic explanation for the severe hypertrophic cardiomyopathy observed in our case [7]. Thus, the c.4511C > T, p. (Ser1504Phe) HECW2 de novo variant was considered as causative of the fetal phenotype. The risk of recurrence for this couple was limited to the risk of germline mosaicism. However, at the next pregnancy, the couple opted for a molecular prenatal diagnosis, acknowledging the risk of NDD. The fetus did not carry the HECW2 variant. In conclusion, we present a novel fetal case of HECW2‐related cardiomyopathy, expanding the phenotypic and genotypic spectrum of HECW2‐associated cardiac disorders, and illustrating that genetic analysis following fetal demise is a crucial step for accurate genetic counseling. A detailed phenotypic breakdown and comparison of these previously reported cardiac features, including prenatal cardiomyopathy and hydrops, are summarized in Supporting Information S1: Table S1. Funding The authors have nothing to report. Ethics Statement Ethics approval statement is not applicable. Genetic analysis was performed as part of routine diagnostic clinical care. Consent Parents’ written consent for autopsy, genetic analysis, and publication was obtained. Conflicts of Interest The authors declare no conflicts of interest. Supporting information Supporting Information S1 Acknowledgments We thank the family, geneticists, and biologists for contributing to this report, in particular Jean Yves QUINT for the Fetal ultrasound. Open access publication funding provided by COUPERIN CY26. Contributor Information Kristina Nimchenko, Email: kristina.nimchenko@aphp.fr. Tania Attie‐Bitach, Email: tania.attie@aphp.fr. Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request. References Associated Data Supplementary Materials Supporting Information S1 Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request.